Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences increases the annual guidance for 2025 The company reports ...

Viehbacher, “Biogen”) announced today that LEQEMBI ® IQLIK™, a subcutaneous autoinjector formulation of lecanemab (generic name), for the treatment of Alzheimer’s disease (AD) has been selected by ...

Oklo is an advanced nuclear reactor developer that is centered on the creation of their Aurora reactors. Read why I rate OKLO ...

LEQEMBI IQLIK, approved by the U.S. FDA in August 2025, is the first and only anti-amyloid treatment to offer an at-home injection after initial treatment of 18 months ...

Representatives from nearly 380 companies converged on the Pennsylvania College of Technology campus at the start of the ...

Switzerland - September 30, 2025 - Kuros Biosciences ("Kuros” or the "Company”), a leader in innovative biologic technologies, today announced the full commercial launch of the MagnetOs™ MIS Delivery ...

YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications - adolescent hidradenitis suppurativa (HS) and ...

Smoke testing will be conducted in select areas of York County, VA over the next two weeks to identify areas where repairs are needed to improve sewer performance and reduce rainwater infiltration.

AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...